Allocation to Directors

RNS Number : 3645P

The MedicX Fund Limited

03 October 2011

 



Press Release

For immediate release                                                                                    

3 October 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Directors of the Company

Members of the Company's Board of Directors elected to participate in the Company's scrip dividend scheme in respect of the September 2011 interim dividend for the quarter ended 30 June 2011, and accordingly were allotted new ordinary shares of no par value in the Company (the "Shares") as disclosed in the table below.  These shares were issued using the previously advised scrip calculation price of 77.73 pence per share.

	Shares Allotted	Total Shares held	Percentage Holding
David Staples (Chairman)	771	44,403	0.023%
Christopher Bennett	126	7,251	0.004%
Shelagh Mason	126	7,251	0.004%
John Hearle	252	14,503	0.008%

The Shares were admitted to the Official List of the FSA and to trading on the Main Market of the London Stock Exchange on 30 September 2011 and rank pari passu with the Company's existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).

End

For further information please contact:

MedicX Group                                                                 [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited                                          [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications                                              [phone]

Charles Ryland/Suzanne Brocks

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 63 properties.

 The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 27 people operating across the UK.  

 The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

RDSDKKDBABKDNCN